ACA(ACA)
ACA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.63B | $2.85B | $3.75B |
| Low | $2.60B | $2.78B | $3.70B |
| High | $2.64B | $2.93B | $3.82B |
| EBITDA Avg | $456M | $494M | $649M |
| Low | $450M | $482M | $641M |
| High | $458M | $508M | $662M |
| EBIT Avg | $266M | $287M | $378M |
| Low | $262M | $280M | $373M |
| High | $267M | $295M | $385M |
| Net Income Avg | $210M | $246M | $351M |
| Low | $206M | $241M | $345M |
| High | $215M | $251M | $360M |
| EPS Avg | $4.28 | $5.02 | $7.17 |
| Low | $4.20 | $4.92 | $7.05 |
| High | $4.38 | $5.13 | $7.35 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $730M | $646M | $607M | $746M | $769M | $683M |
| Low | $724M | $641M | $603M | $741M | $764M | $678M |
| High | $735M | $651M | $613M | $752M | $776M | $689M |
| EBITDA Avg | $126M | $112M | $105M | $129M | $133M | $118M |
| Low | $125M | $111M | $104M | $128M | $132M | $117M |
| High | $127M | $113M | $106M | $130M | $134M | $119M |
| EBIT Avg | $74M | $65M | $61M | $75M | $78M | $69M |
| Low | $73M | $65M | $61M | $75M | $77M | $68M |
| High | $74M | $66M | $62M | $76M | $78M | $69M |
| Net Income Avg | $77M | $50M | $30M | $70M | $84M | $53M |
| Low | $76M | $49M | $30M | $69M | $83M | $53M |
| High | $78M | $50M | $30M | $71M | $85M | $54M |
| EPS Avg | $1.56 | $1.01 | $0.60 | $1.42 | $1.71 | $1.08 |
| Low | $1.55 | $1.00 | $0.60 | $1.41 | $1.70 | $1.08 |
| High | $1.58 | $1.02 | $0.61 | $1.44 | $1.73 | $1.10 |
| Analysts (Rev / EPS) | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |